Dulaglutide is one of the human GLP-1 receptor agonists (GLP-1RAs), administered as a once-weekly subcutaneous injection, and is used worldwide for the treatment of type 2 diabetes (T2DM) [4]. Here, GLP1R is linked to type 2 diabetes mellitus.